Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging

American Journal of Roentgenology

Volumn 180, Issue 4, 2003, Pages 981-985

  Bogaert, Jan ^a   Goldstein, Marcelo ^b   Tannouri, Fadi ^c   Golzarian, Jafar ^c   Dymarkowski, Steven ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Hopital Sainte Anne   (Belgium)

^c ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PERFORMANCE; HEART MUSCLE COMPLIANCE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; IMAGE ENHANCEMENT; ISCHEMIC HEART DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; CONNECTIVE TISSUE; EVALUATION; HEART MUSCLE; MIDDLE AGED; NECROSIS; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CONNECTIVE TISSUE; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; NECROSIS; SENSITIVITY AND SPECIFICITY;

EID: 0037379451     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.180.4.1800981     Document Type: Article

References (12)

1. Abelmann AH, Lorell BH. The challenge of cardiomyopathy. J Am Coll Cardiol 1989;13:1219-1239
2. Kramer CM, Reichek N, Ferrari VA, Theobald T, Dawson J, Axel L. Regional heterogeneity of function in hypertrophic cardiomyopathy. Circulation 1994;90:186-194
3. Kawada N, Sakuma H, Yamakado T, et al. Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects. Radiology 1999;211:129-135
4. Betocchi S, Hess OM, Losi MA, Nonogi H, Krayenbuehl H-P. Regional left ventricular mechanics in hypertrophic cardiomyopathy. Circulation 1993;88:2206-2214
5. Higgins CB, Byrd BF 3rd, Stark D, et al. Magnetic resonance imaging in hypertrophic cardiomyopathy. Am J Cardiol 1985;55:1121-1126
6. Sato T, Yamanari H, Ohe T, Yoshinouchi T. Regional left ventricular contractile dynamics in hypertrophic cardiomyopathy evaluated by magnetic resonance imaging. Heart Vessels 1996;11:248-254
7. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002
8. Tsukihashi H, Ishibashi Y, Shimada T, et al. Changes in gadolinium-DTPA enhanced magnetic resonance signal intensity ratio in hypertrophic cardiomyopathy. J Cardiol 1994;24:185-191
9. Koito H, Suzuki J, Nakamori H, et al. Clinical significance of abnormal high signal intensity of left ventricular myocardium by gadolinium-DTPA enhanced magnetic resonance imaging in hypertrophic cardiomyopathy. J Cardiol 1995;25:163-170
10. Aso H, Takeda K, Ito T, Shiraishi T, Matsumura K, Nakagawa T. Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. Invest Radiol 1998;33:22-32
11. Simonetti O, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2000;218:215-223
12. 99mTc-methoxyisobutyl-isonitrile SPECT. Am Heart J 1992;123:636-645